Germany · Question · Schriftliche Frage
21/9017
mRNA-basierte Impfstoffe im Impfschema der Bundeswehr und Nutzen-Risiko-Bewertung der COVID-19-Impfung bei Soldaten
Introduced
6 November 2026
Last action
6 November 2026 · Schriftliche Frage/Schriftliche Antwort
Status
Beantwortet
Sponsors
—
Subjects
Defence
Source updated
17 November 2026
Records
Official question 21/9017 from Germany at German Bundestag. Dated 6 November 2026. Status: Beantwortet.
Timeline
6 November 2026
Schriftliche Frage/Schriftliche Antwort
mRNA-basierte Impfstoffe im Impfschema der Bundeswehr und Nutzen-Risiko-Bewertung der COVID-19-Impfung bei Soldaten
Source: BT
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
21/9017
This file cannot be previewed here. Use View or Download.
Reading translation
Translate this document into your language. PoliticalRepo does not store a separate copy per EU language.
On-demand whole-document translation with a downloadable PDF (logo + link to the official source). The official file stays authoritative.
21/9017
Drucksache · DE · 6 November 2026
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://dip.bundestag.de/vorgang/mrna-basierte-impfstoffe-im-impfschema-der-bundeswehr-und-nutzen-risiko-bewertun/341796
- Open data entity: https://search.dip.bundestag.de/api/v1/vorgang/341796
- germany · 341796 · source updated 17 November 2026